Lúcia Cristina Jamli Abel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lúcia Cristina Jamli Abel has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Edecio Cunha-Neto
Laboratory of ImmunologyHeart Institute (InCor), Hospital das Clínicas and Department of MedicineFaculdade de Medicina FMUSP, Universidade de Sao Paulo, São Paulo, Brazil
7 shared publications - Charles Mady
Universidade de São Paulo, Brasil
3 shared publications Jorge Kalil
3 shared publications- Jorge Kalil
University of Sao Paulo Medical School
3 shared publications Bárbara Ianni
2 shared publications- Leo Kei Iwai
Laboratory of Applied Toxinology (LETA) and Center of Toxins, Immune-Response and Cell Signaling (CeTICS), Butantan Institute, São Paulo 05503-900, Brazil
2 shared publications
Latest Publications
- 6 February 2017
- Published by IWA Publishing in Journal of Water and Health
- Vol. 15 (3) , 360-366
Effects of drinking desalinated seawater on cell viability and proliferation
Desalination of seawater is becoming an important means to address the increasing scarcity of freshwater resources in the world. Seawater has been used as drinking water in the health, food, and medical fields and various beneficial effects have been suggested, although not confirmed. Given the presence of 63 minerals and trace elements in drinking desalinated seawater (63 DSW), we evaluated their effects on the behavior of tumorigenic and nontumorigenic cells through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and annexin-V-fluorescein isothiocyanate/propidium iodide staining. Our results showed that cell viability and proliferation in the presence of 63 DSW were significantly greater than in mineral water and in the presence of fetal bovine serum in a dose-dependent manner. Furthermore, 63 DSW showed no toxic effect on murine embryonic fibroblast (NIH-3T3) and murine melanoma (B16-F10) cells. In another assay, we also showed that pre-treatment of non-adherent THP-1 cells with 63 DSW reduces apoptosis incidence, suggesting a protective effect against cell death. We conclude that cell viability and proliferation were improved by the mineral components of 63 DSW and this effect can guide further studies on health effects associated with DSW consumption.
- 6 February 2017
- Published by IWA Publishing in Journal of Water and Health
- Vol. 15 (3) , 360-366
Effects of drinking desalinated seawater on cell viability and proliferation
Desalination of seawater is becoming an important means to address the increasing scarcity of freshwater resources in the world. Seawater has been used as drinking water in the health, food, and medical fields and various beneficial effects have been suggested, although not confirmed. Given the presence of 63 minerals and trace elements in drinking desalinated seawater (63 DSW), we evaluated their effects on the behavior of tumorigenic and nontumorigenic cells through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and annexin-V-fluorescein isothiocyanate/propidium iodide staining. Our results showed that cell viability and proliferation in the presence of 63 DSW were significantly greater than in mineral water and in the presence of fetal bovine serum in a dose-dependent manner. Furthermore, 63 DSW showed no toxic effect on murine embryonic fibroblast (NIH-3T3) and murine melanoma (B16-F10) cells. In another assay, we also showed that pre-treatment of non-adherent THP-1 cells with 63 DSW reduces apoptosis incidence, suggesting a protective effect against cell death. We conclude that cell viability and proliferation were improved by the mineral components of 63 DSW and this effect can guide further studies on health effects associated with DSW consumption.
- Open Access
- 9 July 2014
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2014, 1-7
Induction of IL-12 Production in Human Peripheral Monocytes byTrypanosoma cruziIs Mediated by Glycosylphosphatidylinositol-Anchored Mucin-Like Glycoproteins and Potentiated by IFN-γand CD40-CD40L Interactions
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), is characterized by immunopathology driven by IFN-γ secreting Th1-like T cells. T. cruzi has a thick coat of mucin-like glycoproteins covering its surface, which plays an important role in parasite invasion and host immunomodulation. It has been extensively described that T. cruzi or its products—like GPI anchors isolated from GPI-anchored mucins from the trypomastigote life cycle stage (tGPI-mucins)—are potent inducers of proinflammatory responses (i.e., cytokines and NO production) by IFN-γ primed murine macrophages. However, little is known about whether T. cruzi or GPI-mucins exert a similar action in human cells. We therefore decided to further investigate the in vitro cytokine production profile from human mononuclear cells from uninfected donors exposed to T. cruzi as well as tGPI-mucins. We observed that both living T. cruzi trypomastigotes and tGPI-mucins are potent inducers of IL-12 by human peripheral blood monocytes and this effect depends on CD40-CD40L interaction and IFN-γ. Our findings suggest that the polarized T1-type cytokine profile seen in T. cruzi infected patients might be a long-term effect of IL-12 production induced by lifelong exposure to T. cruzi tGPI-mucins.
- 9 July 2014
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2014, 1-7
Open AccessInduction of IL-12 Production in Human Peripheral Monocytes byTrypanosoma cruziIs Mediated by Glycosylphosphatidylinositol-Anchored Mucin-Like Glycoproteins and Potentiated by IFN-γand CD40-CD40L Interactions
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi (T. cruzi), is characterized by immunopathology driven by IFN-γ secreting Th1-like T cells. T. cruzi has a thick coat of mucin-like glycoproteins covering its surface, which plays an important role in parasite invasion and host immunomodulation. It has been extensively described that T. cruzi or its products—like GPI anchors isolated from GPI-anchored mucins from the trypomastigote life cycle stage (tGPI-mucins)—are potent inducers of proinflammatory responses (i.e., cytokines and NO production) by IFN-γ primed murine macrophages. However, little is known about whether T. cruzi or GPI-mucins exert a similar action in human cells. We therefore decided to further investigate the in vitro cytokine production profile from human mononuclear cells from uninfected donors exposed to T. cruzi as well as tGPI-mucins. We observed that both living T. cruzi trypomastigotes and tGPI-mucins are potent inducers of IL-12 by human peripheral blood monocytes and this effect depends on CD40-CD40L interaction and IFN-γ. Our findings suggest that the polarized T1-type cytokine profile seen in T. cruzi infected patients might be a long-term effect of IL-12 production induced by lifelong exposure to T. cruzi tGPI-mucins.
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S131
P196 INVESTIGATION OF HEPATITIS C VIRUS ADAPTATION TO HOST GENETIC POLYMORPHISMS
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S131
P196 INVESTIGATION OF HEPATITIS C VIRUS ADAPTATION TO HOST GENETIC POLYMORPHISMS
- 27 November 2012
- Published by FapUNIFESP (SciELO) in Ciência Rural
- Vol. 42 (12) , 2229-2234
Associação de imunoestimulante com anti-helmíntico no tratamento da verminose em ovinos
Este estudo teve como objetivo verificar a eficiência do uso de imunoestimulante associado a anti-helmíntico no tratamento das helmintoses de ovinos. Os animais do grupo I (n=29) receberam o anti-helmíntico albendazole (11mg kg-1) em administração única e o imunoestimulante composto de Propionibacterium granulosum (16ug kg-1) e lipopolissacarídeo (LPS) de Escherichia coli (1,2ug kg-1) em duas doses com intervalo de 48 horas e os animais do grupo II (n=29) receberam o anti-helmíntico albendazole (11mg kg-1). Amostras foram colhidas semanalmente durante 28 dias para a realização da contagem total e diferencial de leucócitos, hematócrito e contagem de ovos por grama de fezes (OPG). Os animais que receberam imunoestimulante associado a anti-helmíntico apresentaram aumento significativo dos valores de eosinófilos e linfócitos (P0,05). Com base nesses resultados, pode-se concluir que imunoestimulantes podem ser utilizados associados a anti-helmínticos como alternativa terapêutica no tratamento das helmintíases em ovinos, uma vez que promovem a ativação da resposta imune com participação de células e mediadores importantes para a eliminação de helmintos em ovinos.
- 27 November 2012
- Published by FapUNIFESP (SciELO) in Ciência Rural
- Vol. 42 (12) , 2229-2234
Associação de imunoestimulante com anti-helmíntico no tratamento da verminose em ovinos
Este estudo teve como objetivo verificar a eficiência do uso de imunoestimulante associado a anti-helmíntico no tratamento das helmintoses de ovinos. Os animais do grupo I (n=29) receberam o anti-helmíntico albendazole (11mg kg-1) em administração única e o imunoestimulante composto de Propionibacterium granulosum (16ug kg-1) e lipopolissacarídeo (LPS) de Escherichia coli (1,2ug kg-1) em duas doses com intervalo de 48 horas e os animais do grupo II (n=29) receberam o anti-helmíntico albendazole (11mg kg-1). Amostras foram colhidas semanalmente durante 28 dias para a realização da contagem total e diferencial de leucócitos, hematócrito e contagem de ovos por grama de fezes (OPG). Os animais que receberam imunoestimulante associado a anti-helmíntico apresentaram aumento significativo dos valores de eosinófilos e linfócitos (P0,05). Com base nesses resultados, pode-se concluir que imunoestimulantes podem ser utilizados associados a anti-helmínticos como alternativa terapêutica no tratamento das helmintíases em ovinos, uma vez que promovem a ativação da resposta imune com participação de células e mediadores importantes para a eliminação de helmintos em ovinos.
- 8 September 2009
- Published by Wiley in Parasite Immunology
- Vol. 31 (10) , 604-612
Adjuvant effect of LPS and killedPropionibacterium acneson the development of experimental gastrointestinal nematode infestation in sheep
Summary: Gastrointestinal helminthic infection is an important worldwide sheep disease. The emergence of anthelminthic resistance has led to drives to seek new means of therapeutic control of helminthiasis in sheep. Several data demonstrated the adjuvant effect ofPropionibacterium acneson resistance to infection. Herein, we evaluate the adjuvant effect of the commercial suspension containing LPS andP. acneson experimental helminthiasis. Sheep received three doses of LPS andP. acnescommercial suspension or saline 0·9% (control group). Both groups received orallyHaemonchus contortusinfective larvae on day 0. Parasitological, haematological, lymphoproliferation analysis, IL‐5 and IgE determination were made once a week until 35th day after infection. Our results revealed increase on packed cell volumes on day 14, in LPS + P. acnestreated group. On 21st and 35th days after infection in the same group occurred increase on circulating eosinophils and lymphocytes, and also in the lymphoproliferative response to mitogen. On 35th day, the faecal eggs peak in LPS + P. acnestreated group was significantly lower than control. A negative correlation between faecal eggs counts and circulating eosinophils in the immunostimulant treated group was also observed. Our findings suggest that LPS + P. acnessuspension can be used as a strategy to control helminthiasis in sheep.
- 8 September 2009
- Published by Wiley in Parasite Immunology
- Vol. 31 (10) , 604-612
Adjuvant effect of LPS and killedPropionibacterium acneson the development of experimental gastrointestinal nematode infestation in sheep
Summary: Gastrointestinal helminthic infection is an important worldwide sheep disease. The emergence of anthelminthic resistance has led to drives to seek new means of therapeutic control of helminthiasis in sheep. Several data demonstrated the adjuvant effect ofPropionibacterium acneson resistance to infection. Herein, we evaluate the adjuvant effect of the commercial suspension containing LPS andP. acneson experimental helminthiasis. Sheep received three doses of LPS andP. acnescommercial suspension or saline 0·9% (control group). Both groups received orallyHaemonchus contortusinfective larvae on day 0. Parasitological, haematological, lymphoproliferation analysis, IL‐5 and IgE determination were made once a week until 35th day after infection. Our results revealed increase on packed cell volumes on day 14, in LPS + P. acnestreated group. On 21st and 35th days after infection in the same group occurred increase on circulating eosinophils and lymphocytes, and also in the lymphoproliferative response to mitogen. On 35th day, the faecal eggs peak in LPS + P. acnestreated group was significantly lower than control. A negative correlation between faecal eggs counts and circulating eosinophils in the immunostimulant treated group was also observed. Our findings suggest that LPS + P. acnessuspension can be used as a strategy to control helminthiasis in sheep.
- 25 February 2009
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 128 (1-3) , 289-290
Effect of anthelminthic combined with immunostimulant on gastrointestinal sheep nematodes
- 25 February 2009
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 128 (1-3) , 289-290
Effect of anthelminthic combined with immunostimulant on gastrointestinal sheep nematodes
- 1 August 2005
- Published by Elsevier in Microbes and Infection
- Vol. 7 (11-12) , 1184-1195
T cell epitope characterization in tandemly repetitive Trypanosoma cruzi B13 protein
- 1 August 2005
- Published by Elsevier in Microbes and Infection
- Vol. 7 (11-12) , 1184-1195
T cell epitope characterization in tandemly repetitive Trypanosoma cruzi B13 protein
- 1 November 2004
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (5) , 1583-1591
Rheumatic Heart Disease
- 1 November 2004
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (5) , 1583-1591
Rheumatic Heart Disease
- 1 August 2001
- Published by Elsevier in Journal of Autoimmunity
- Vol. 17 (1) , 99-107
Chronic Chagas' Disease Cardiomyopathy Patients Display an Increased IFN-γ Response to Trypanosoma cruzi Infection
- 1 August 2001
- Published by Elsevier in Journal of Autoimmunity
- Vol. 17 (1) , 99-107
Chronic Chagas' Disease Cardiomyopathy Patients Display an Increased IFN-γ Response to Trypanosoma cruzi Infection